Carregant...
Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
COVID-19 vaccines based on the Spike protein of SARS-CoV-2 have been developed that appear to be largely successful in stopping infection. However, vaccine escape variants might arise leading to a re-emergence of COVID. In anticipation of such a scenario, the identification of repurposed drugs that...
Guardat en:
| Publicat a: | bioRxiv |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cold Spring Harbor Laboratory
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872348/ https://ncbi.nlm.nih.gov/pubmed/33564760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.01.31.428851 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|